Soleno Therapeutics, Inc.SLNONASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Trend
Above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
102.99%
↑ 143% above average
Average (39q)
-239.88%
Historical baseline
Range
High:187.83%
Low:-6458.54%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 102.99% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 100.00% |
| Q4 2017 | -3057.34% |
| Q3 2017 | -6458.54% |
| Q2 2017 | -173.21% |
| Q1 2017 | -8.92% |
| Q4 2016 | 187.83% |
| Q3 2016 | -89.19% |
| Q2 2016 | -164.29% |
| Q1 2016 | 7.46% |
| Q4 2015 | -142.02% |